-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-515561-34-01
6
2025-08-04
Acute ischemic stroke with recent ingestion of direct oral anticoagula
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2023-509717-36-00
5
2024-12-16
AF patients who have undergone successful PCI
-
2024-514917-36-00
5
2024-11-21
Patients with High Risk Neuroblastoma
-
2024-511336-28-00
9
2023-08-11
Leukemia in childhood
-
2023-505634-94-00
10
2023-02-02
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythe
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2024-513446-12-00
4
2022-05-03
Living donor kidney transplantation
-
2024-511264-89-00
4
2022-04-11
Glioblastoma
-
2024-513723-16-00
4
2021-10-21
metastatic colorectal cancer
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2023-508926-91-00
5
2019-12-05
Stage IV childhood renal tumour with pulmonary +/- non-pulmonary
metas
-
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
-
2024-515523-11-00
5
2025-06-09
Chronic Weight Management
-
2024-518321-15-00
4
2025-05-30
Asthma
-
2022-502878-16-00
5
2025-01-23
Acute ischemic strokes with incomplete reperfusion
-
2023-506334-75-00
5
2024-07-12
Pulmonary Arterial Hypertension
-
2024-515224-37-00
4
2023-08-29
Patients with MSI-high or MMR-deficient stage III colorectal cancer wh
-
2024-513462-19-00
5
2023-03-30
Refractory Chronic Cough, Including Unexplained Chronic Cough
-
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
-
2022-503105-38-00
5
2021-10-22
MET-driven, unresectable and locally advanced or metastatic Papillary
-
2024-512682-14-00
4
2020-04-06
Non-resectable hepatocellular carcinoma (HCC)
-
2023-506782-56-00
5
2020-03-10
RET-Mutant Medullary Thyroid Cancer